ISB News

Cancer Genomics Cloud: ISB and Google Featured in MIT Tech Review

ISB Recieves $6.5M NIH Contract to Create Cancer Genomics Cloud with Google and SRA International (Image credit: MIT Tech Review)

(Above illustration from MIT Technology Review.)

MIT Technology Review published an article about the launch of Google Genomics and included a mention of ISB’s new Cancer Genomics Cloud project. ISB received an up-to $6.5 million, two-year NIH contract in collaboration with Google and SRA International.

From the MIT Technology Review article:

The idea is to create “cancer genome clouds” where scientists can share information and quickly run virtual experiments as easily as a Web search, says Sheila Reynolds, a research scientist at the Institute for Systems Biology in Seattle. “Not everyone has the ability to download a petabyte of data, or has the computing power to work on it,” she says.

This article also was cited in The Scientist here.

Researchers interested in participating in the Cancer Genomics Cloud project, please visit cgc.isbscience.net.

Read more about ISB’s Cancer Genomics Cloud project:

cancerGenomicsCloud

 

Related Articles

  • ISB Unveils New Brand Ahead of 20th Anniversary

    We created a new brand identity — including logo and tag line — to reflect ISB’s evolution since our inception in 2000, and ahead of our 20th anniversary. ISB is proud to be a part of the vibrant research community in Seattle, and is committed to translational and collaborative science.

  • New Method to Detect, Analyze Rare T Cells Another Step Toward Personalized Cancer Vaccines

    Members of ISB’s Heath Lab and their collaborators have developed a way to sensitively detect and analyze neoantigen-specific T-cell populations from tumors and blood. This promising development may have implications for creating targeted, individual-specific cancer vaccines.

  • The Cancer Paradox

    ISB’s Dr. Sui Huang uses the theory of complex systems and applies it to cancer research. In this video Q&A, he discusses the cancer paradox and highlights the importance of understanding the mechanism of what cancer treatments can backfire in order to open a new avenue for therapy and treatments.

Show More Articles